Syngene International Limited SYNGENE.BO Stock
Syngene International Limited Price Chart
Syngene International Limited SYNGENE.BO Financial and Trading Overview
Syngene International Limited stock price | 748.4 INR |
Previous Close | 749.75 INR |
Open | 752.95 INR |
Bid | 740.35 INR x 0 |
Ask | 741.35 INR x 0 |
Day's Range | 739.6 - 752.95 INR |
52 Week Range | 530.1 - 755.55 INR |
Volume | 30.83K INR |
Avg. Volume | 22.69K INR |
Market Cap | 297.85B INR |
Beta (5Y Monthly) | 0.481506 |
PE Ratio (TTM) | 64.70743 |
EPS (TTM) | 12.42 INR |
Forward Dividend & Yield | 0.5 (0.069%) |
Ex-Dividend Date | June 30, 2023 |
1y Target Est | 622 INR |
SYNGENE.BO Valuation Measures
Enterprise Value | 292.49B INR |
Trailing P/E | 64.70743 |
Forward P/E | 37.212456 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 9.125956 |
Price/Book (mrq) | 8.205055 |
Enterprise Value/Revenue | 8.962 |
Enterprise Value/EBITDA | 27.933 |
Trading Information
Syngene International Limited Stock Price History
Beta (5Y Monthly) | 0.481506 |
52-Week Change | 39.35% |
S&P500 52-Week Change | 20.43% |
52 Week High | 755.55 INR |
52 Week Low | 530.1 INR |
50-Day Moving Average | 675.61 INR |
200-Day Moving Average | 606.93 INR |
SYNGENE.BO Share Statistics
Avg. Volume (3 month) | 22.69K INR |
Avg. Daily Volume (10-Days) | 16.79K INR |
Shares Outstanding | 402.02M |
Float | 178.23M |
Short Ratio | N/A |
% Held by Insiders | 55.56% |
% Held by Institutions | 24.43% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.5 |
Trailing Annual Dividend Yield | 0.066% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.0434 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 14.22% |
Operating Margin (ttm) | 20.85% |
Gross Margin | 73.64% |
EBITDA Margin | 32.08% |
Management Effectiveness
Return on Assets (ttm) | 7.46% |
Return on Equity (ttm) | 13.43% |
Income Statement
Revenue (ttm) | 32.64B INR |
Revenue Per Share (ttm) | 81.45 INR |
Quarterly Revenue Growth (yoy) | 40.50% |
Gross Profit (ttm) | 23.33B INR |
EBITDA | 10.47B INR |
Net Income Avi to Common (ttm) | 4.64B INR |
Diluted EPS (ttm) | 11.45 |
Quarterly Earnings Growth (yoy) | 21.00% |
Balance Sheet
Total Cash (mrq) | 13.56B INR |
Total Cash Per Share (mrq) | 33.85 INR |
Total Debt (mrq) | 8.15B INR |
Total Debt/Equity (mrq) | 22.53 INR |
Current Ratio (mrq) | 2.041 |
Book Value Per Share (mrq) | 90.298 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.23B INR |
Levered Free Cash Flow (ttm) | 2.51B INR |
Profile of Syngene International Limited
Country | India |
State | N/A |
City | Bengaluru |
Address | Biocon SEZ, Biocon Park, |
ZIP | 560099 |
Phone | 91 80 2808 2808 |
Website | https://www.syngeneintl.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also offers exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services. In addition, the company provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical, central lab, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. Further, it offers other drug modalities, which include peptides, oligonucleotide synthesis, antibody drug conjugate, PROTACs, and CAR T-cell therapy services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, specialty chemical, and other companies. It has partnerships and collaborations with Bristol-Myers Squibb Co.; Baxter Inc.; and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.
Q&A For Syngene International Limited Stock
What is a current SYNGENE.BO stock price?
Syngene International Limited SYNGENE.BO stock price today per share is 748.4 INR.
How to purchase Syngene International Limited stock?
You can buy SYNGENE.BO shares on the BSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Syngene International Limited?
The stock symbol or ticker of Syngene International Limited is SYNGENE.BO.
Which industry does the Syngene International Limited company belong to?
The Syngene International Limited industry is Biotechnology.
How many shares does Syngene International Limited have in circulation?
The max supply of Syngene International Limited shares is 400.74M.
What is Syngene International Limited Price to Earnings Ratio (PE Ratio)?
Syngene International Limited PE Ratio is 60.25765200 now.
What was Syngene International Limited earnings per share over the trailing 12 months (TTM)?
Syngene International Limited EPS is 12.42 INR over the trailing 12 months.
Which sector does the Syngene International Limited company belong to?
The Syngene International Limited sector is Healthcare.